Gordon Mills Selected Research

Melanoma (Melanoma, Malignant)

10/2023	Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity.
11/2021	TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
12/2018	Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis.
1/2018	Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
10/2017	PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
1/2013	Perturbation biology: inferring signaling networks in cellular systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gordon Mills Research Topics

Disease

19	Neoplasms (Cancer) 10/2023 - 01/2005
6	Melanoma (Melanoma, Malignant) 10/2023 - 01/2013
4	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2006
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2014
2	Glioma (Gliomas) 12/2021 - 06/2015
2	Hypoxia (Hypoxemia) 01/2012 - 12/2008
2	Lung Neoplasms (Lung Cancer) 08/2010 - 05/2008
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Myocardial Infarction 12/2021
1	ST Elevation Myocardial Infarction 12/2021
1	COVID-19 12/2021
1	Nevus (Nevi) 12/2018
1	Carcinoma (Carcinomatosis) 05/2009
1	Squamous Cell Carcinoma of Head and Neck 03/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 03/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2008
1	Parkinson Disease (Parkinson's Disease) 12/2008
1	Glioblastoma (Glioblastoma Multiforme) 05/2008
1	Ovarian Epithelial Carcinoma 03/2008
1	Ascites 01/2007
1	Carcinogenesis 11/2006

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2015
3	RNA (Ribonucleic Acid)IBA 10/2023 - 06/2015
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2023 - 06/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2015 - 01/2015
2	lysophosphatidic acidIBA 01/2012 - 01/2007
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 03/2009
1	Lipid NanoparticlesIBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2022
1	Tumor Biomarkers (Tumor Markers)IBA 12/2022
1	Lipid Bilayers (Lipid Bilayer)IBA 12/2022
1	PlatinumIBA 01/2022
1	Ribose (D-Ribose)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 12/2021
1	alpha-2'-deoxythioguanosineIBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 12/2021
1	NucleosidesIBA 12/2021
1	IronIBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 06/2015
1	ChromatinIBA 01/2014
1	raf KinasesIBA 01/2013
1	alkylglycerophosphoethanolamine phosphodiesteraseIBA 01/2012
1	Lysophosphatidic Acid ReceptorsIBA 01/2012
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2010
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	Steroid Receptors (Steroid Receptor)IBA 08/2010
1	Gefitinib (Iressa)FDA Link 08/2010
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 08/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2009
1	TensinsIBA 05/2009
1	Antisense DNAIBA 03/2009
1	deguelinIBA 12/2008
1	Protein Isoforms (Isoforms)IBA 05/2008
1	Complementary DNA (cDNA)IBA 05/2008
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 05/2008
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2008
1	Oral ContraceptivesIBA 03/2008
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2007
1	lysophosphatidylserineIBA 01/2007
1	lysophosphatidylinositolIBA 01/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2007
1	sphingosine phosphorylcholineIBA 01/2007
1	LysophospholipidsIBA 01/2007
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2007
1	EnzymesIBA 01/2007
1	Conditioned Culture MediaIBA 01/2007
1	Estrogen Receptor alphaIBA 11/2006
1	I-kappa B KinaseIBA 11/2006

Therapy/Procedure

8	Therapeutics 11/2021 - 01/2007
2	Chemoprevention 12/2008 - 01/2005
1	Immunotherapy 10/2023
1	Percutaneous Coronary Intervention 12/2021
1	Drug Therapy (Chemotherapy) 03/2008